SARS CoV-2 Pathogenesis and Immune Response

被引:0
|
作者
Dinc, Harika Oyku [1 ]
Yuksel Mayda, Pelin [1 ]
机构
[1] Bezmialem Vakif Univ, Dept Pharmaceut Microbiol, Fac Pharm, Istanbul, Turkey
来源
BEZMIALEM SCIENCE | 2020年 / 8卷
关键词
Coronavirus; COVID-19; pathogenesis; immunology; SARS-CoV-2; COVID-19;
D O I
10.14235/bas.galenos.2020.4776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The agent responsible for the epidemic that first appeared in Wuhan, China, in December 2019 was detected to be the new coronavirus (2019-nCoV). Later, the virus that caused respiratory tract infection was discovered to be a member of the beta-coronavirus family, it was named as severe acute respiratory syndrome-CoV2 (SARS-CoV 2), and the disease it caused was called CoV infection disease-19 (COVID-19). The epidemic started in China, spread rapidly first to East Asian countries, then Europe and America, affected the whole world, and was declared a pandemic by the World Health Organization. This review presents an overview of SARS-CoV2 and aims to examine its intracellular pathogenesis and host immune responses.
引用
收藏
页码:153 / 156
页数:4
相关论文
共 50 条
  • [41] Homology between SARS CoV-2 and human proteins
    Khavinson, Vladimir
    Terekhov, Alexander
    Kormilets, Dmitry
    Maryanovich, Alexander
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [42] Vertical transmission of SARS CoV-2: a systematic review
    Deniz, Melis
    Tezer, Hasan
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (14): : 2655 - 2662
  • [43] Development of an Inactivated Vaccine against SARS CoV-2
    Pavel, Shaikh Terkis Islam
    Yetiskin, Hazel
    Uygut, Muhammet Ali
    Aslan, Ahmet Furkan
    Aydin, Gunsu
    Inan, Oznur
    Kaplan, Busra
    Ozdarendeli, Aykut
    VACCINES, 2021, 9 (11)
  • [44] Deep Learning for SARS COV-2 Genome Sequences
    Whata, Albert
    Chimedza, Charles
    IEEE ACCESS, 2021, 9 : 59597 - 59611
  • [45] Profile of specific antibodies to the SARS- CoV-2
    Mou, Danlei
    Feng, Huahua
    Cao, Ruiyuan
    Weng, Xing
    Zhao, Lizhe
    Yang, Lingling
    Jin, Ronghua
    Chen, Weijun
    JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 70 (03)
  • [46] Investigation of SARS CoV-2 virus in environmental surface
    Dargahi, Abdollah
    Jeddi, Farhad
    Vosoughi, Mehdi
    Karami, Chiman
    Hadisi, Aidin
    Mokhtari, S. Ahamad
    Ghobadi, Hasan
    Alighadri, Morteza
    Haghighi, Somayeh Biparva
    Sadeghi, Hadi
    ENVIRONMENTAL RESEARCH, 2021, 195
  • [47] SARS CoV-2 vaccine AND rituximab, timing might be a key for a better vaccine response
    Verhoeven, Frank
    Lepiller, Quentin
    Hecquet, Sophie
    Prati, Clement
    Wendling, Daniel
    JOINT BONE SPINE, 2021, 88 (06)
  • [48] Antibody Response to Sars- Cov-2 Mrna Vaccine in Kidney Transplant Recipients
    Rahman, R. Mohamed Abdul
    Alkadi, M.
    Abuhelaiqa, E.
    Jarman, M.
    Nauman, A.
    Fituri, O.
    Asim, M.
    Hamad, A.
    Tohid, H.
    Coyle, P.
    Abu Raddad, L.
    Al-Malki, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 771 - 772
  • [49] Response to Letters to the Editor, " Sources of SARS CoV-2 and Other Microorganisms in Dental Aerosols"
    Meethil, A.
    Saraswat, S.
    Chaudhary, P. P.
    Dabdoub, S.
    Kumar, P.
    JOURNAL OF DENTAL RESEARCH, 2022, 101 (02) : 238 - 239
  • [50] Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma
    Nooka, Ajay K.
    Shanmugasundaram, Uma
    Cheedarla, Narayana
    Verkerke, Hans
    Edara, Venkata V.
    Valanparambil, Rajesh
    Kaufman, Jonathan L.
    Hofmeister, Craig C.
    Joseph, Nisha S.
    Lonial, Sagar
    Azeem, Maryam
    Manalo, Julia
    Switchenko, Jeffrey M.
    Chang, Andres
    Linderman, Susanne L.
    Roback, John D.
    Dhodapkar, Kavita M.
    Ahmed, Rafi
    Suthar, Mehul S.
    Neish, Andrew S.
    Dhodapkar, Madhav, V
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (26) : 3057 - +